Catalyst Pharmaceuticals, Inc. (CPRX)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Catalyst Pharmaceuticals, Inc. (CPRX)
Go deeper and ask any question about CPRX
Company Performance
Current Price
as of Sep 13, 2024$20.22
P/E Ratio
37.90
Market Cap
$2.4B
Description
Catalyst Pharmaceuticals, Inc. is a commercial-stage, patient-centric biopharmaceutical company, which focuses on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult to treat diseases. The company was founded by Hubert E. Huckel and Patrick J. McEnany in January 2002 and is headquartered in Coral Gables, FL.
Metrics
Overview
- HQCoral Gables, FL
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerCPRX
- Price$20.22-0.34%
Trading Information
- Market Cap$2.40B
- Float86.30%
- Average Daily Volume (1m)862,266
- Average Daily Volume (3m)1,099,894
- EPS$0.58
Company
- Revenue$434.48M
- Rev Growth (1yr)23.23%
- Net Income$40.79M
- Gross Margin79.83%
- EBITDA Margin51.95%
- EBITDA$63.75M
- EV$1.56B
- EV/Revenue3.59
- P/E37.90
- P/S5.80
Documents
SEC Filings
Factset Street Account
Earnings Calls
Factset